A Livestrong Cancer Institutes Podcast Discussion with Professor Kowalski-Muegge
Professor Kowalski-Muegge was invited to talk about her development and lead of the Livestrong Cancer Institute’s first-ever research molecular tumor board, TOMWAY (Total Molecular Profiles with Actionable Yields). In her leadership role as Associate Director, Cancer Clinical Genomics, Dr. Kowalski-Muegge is leading efforts to educate and inform on molecularly-targeted treatment for cancer.